SciELO - Scientific Electronic Library Online

 
vol.63 número3Covid-19, impacto psicosocial en estudiantes de medicinaEvidencia molecular de la infección por Trypanosoma cruzi TcI en Meccus pallidipennis capturados en el municipio de Tepecoacuilco, Guerrero índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Salud Pública de México

versión impresa ISSN 0036-3634

Salud pública Méx vol.63 no.3 Cuernavaca may./jul. 2021  Epub 20-Feb-2023

https://doi.org/10.21149/11890 

Cartas al editor

Dyslipidemia and severe periodontitis among patients with type 2 diabetes

Dislipidemia y periodontitis severa entre pacientes con diabetes tipo 2

María Jiménez-Corona, MD, MSc, PhD(1) 

José Falcón-Flores, MSc(2) 

Aída Borges-Yáñez, DDS, MPH, PhD(3) 

Roberto Castrejón-Pérez, DDS, MSc, PhD(4) 

Aida Jiménez-Corona, MD, MSc, PhD(2  ,5)  aidaajc@gmail.com

(1) Departamento de Epidemiología, Instituto Nacional de Cardiología Ignacio Chávez. Mexico City, Mexico.

(2) Departamento de Epidemiología Ocular y Salud Visual, Instituto de Oftalmología Fundación Conde de Valenciana. Mexico City, Mexico.

(3) División de Estudios de Posgrado e Investigación, Facultad de Odontología, Universidad Nacional Autónoma de México. Mexico City, Mexico.

(4) Instituto Nacional de Geriatría. Mexico City, Mexico.

(5) Dirección General de Epidemiología, Secretaría de Salud. Mexico City, Mexico


Dear editor: Among the major chronic complications associated with poor metabolic control in people with diabetes is periodontal disease (36.4%). Some of the main risk factors for periodontal disease in persons with diabetes are disease duration, poor metabolic control, smoking, poor oral hygiene habits, and inadequate diet.1 Other suggested risk factor is dyslipidemia, some studies have found an increase in levels of total cholesterol, LDL cholesterol, and triglycerides in patients with severe periodontitis, as well as a rise in triglycerides in those without periodontal treatment.2 The objective of this study was to determine the association between dyslipidemia and severe periodontitis among patients with type 2 diabetes (T2DM).

This cross-sectional study included 78 participants diagnosed with T2DM receiving care at the Metabolic Syndrome Clinic at the Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER) in Mexico City, Mexico. Dyslipidemia was defined as triglycerides ≥150 mg/dL and HDL-cholesterol <50 mg/dL in women and <40 mg/dL in men. Oral clinical evaluation was performed by three dentists previously standardized (kappa coefficient ≥0.80) for measurement of dental plaque, dental calculus, and loss of attachment using a periodontal probe PCP2 (Hu-Friedy). Severe periodontitis was defined as at least two interproximal sites with ≥6 mm clinical attachment loss and at least one site with probing depth ≥5 mm.

Mean diabetes duration of the participants was 10.1 years (s.d. 6.6); 39.7% had dyslipidemia and 65.3% had severe periodontitis. The prevalence of severe periodontitis was higher in patients with diabetes duration ≥5 years (70.8%, 95%CI 58.2-80.8) and with dyslipidemia (77.4%, 95%CI 59.3-88.9) as compared with patients with diabetes duration <5 years (46.8%, 95%CI 24.0-70.9, p=1.32), and without dyslipidemia (58.5%; 95%CI 43.7-71.9, p=0.045). After adjustment for diabetes duration and dental calculus (table I), patients with dyslipidemia had 3.18 (95%CI 1.03-9.82, p=0.044) times the probability of severe periodontitis compared with patients without dyslipidemia. As well, patients with dyslipidemia had a greater probing depth (4.81 mm [95%CI 4.19-5.42], p<0.001) than those without. Also, probing depth was greater (3.73 mm [95%CI 2.76-4.70], p<0.001) in patients with high triglyceride levels and in those with low HDL-cholesterol (2.41 mm [95%CI 1.36-3.45], p<0.001).

Table I: Regression models for dyslipidemia and severe periodontitis, and probing depth among patients with type 2 diabetes. Metabolic Syndrome Clinic, INER, Mexico City, 2010 

Periodontitis

Adjusted OR

(95%CI)

p value

Adjusted OR

(95%CI)

p value

Adjusted OR

(95%CI)

p value

Duration of diabetes ≥5 years

5.68 (1.53-21.05)

0.009

4.82 (1.34-17-36)

0.016

4.09 (1.19-14.04)

0.025

Dental calculus (poor hygiene)

3.53 (1.12-11.07)

0.030

2.84 (0.94-8.60)

0.063

2.76 (0.93-8.18)

0.067

High triglyceride levels*

-

-

1.89 (0.67-5.29)

0.224

-

-

Low HDL-cholesterol levels*

-

-

-

-

1.73 (0.55-5.40)

0.343

Dyslipidemia*

3.18 (1.03-9.82)

0.044

-

-

-

-

Probing depth

Adjusted β

(95%CI)

p value

Adjusted β

(95%CI)

p value

Adjusted β

(95%CI)

p value

Duration of diabetes ≥5 years

0.31 (-0.30-0.93)

0.315

0.24 (-0.83-1.31)

0.654

-0.77 (-2.06-0.52)

0.238

Dental calculus (poor hygiene)

0.42 (-0.21-1.06)

0.192

0.02 (-0.90-0.95)

0.961

-0.48 (-1.59-0.62)

0.386

High triglyceride levels*

-

-

3.73 (2.76-4.70)

<0.001

-

Low HDL-cholesterol levels*

-

-

-

2.41 (1.36- 3.45)

<0.001

Dyslipidemia

4.81 (4.19-5.42)

<0.001

-

-

* Triglyceride levels: high was ≥150 mg/dL and normal <150 mg/dL. HDL-cholesterol: low was <40 mg/dL in men and <50 mg/dL in women; normal was ≥40 mg/dL in men and ≥50 mg/dL in women.

Dyslipidemia was defined as high levels of triglycerides and low levels of HDL-cholesterol, and non-dyslipidemia as normal levels of HDL-cholesterol regardless of triglyceride levels.

Hosmer-Lemeshow goodness-of-fit test model: Model 1, p=0.821; Model 2, p=0.743; Model 3, p=0.935

INER:Instituto Nacional de Enfermedades Respiratorias

Perhaps the association between periodontitis and dyslipidemia is caused by the increase of cytokines as a response to the inflammatory process induced by dyslipidemia. This condition affects immunological and hormonal profiles and causes endotoxemia, leading to an increase in the levels of pro-inflammatory cytokines. This mechanism is exa cerbated in the case of patients with diabetes.3 Then, it is thus necessary to design strategies that consider comprehensive care of people with diabetes to reduce oral complications.

Referencias

Saini R, Saini S, Sugandha R. Periodontal disease: The sixth complication of diabetes. J Family Community Med. 2011;18(1):31. https://doi.org/10.4103/1319-1683.78636 [ Links ]

Kalsi D, Chopra J, Sood A. Association of lipid profile test values, type-2 diabetes mellitus, and periodontitis. Indian J Dent. 2015;6(2):81-4. https://doi.org/10.4103/0975-962X.157270 [ Links ]

Zhou X, Zhang W, Liu X, Zhang W, Li Y. Interrelationship between diabetes and periodontitis: Role of hyperlipidemia. Arch Oral Biol. 2015;60(4):667-74. https://doi.org/10.1016/j.archoralbio.2014.11.008 [ Links ]

Declaration of conflict of interests. The authors declare that they have no conflict of interests.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License